Claims for Patent: 11,065,239

✉ Email this page to a colleague

Summary for Patent: 11,065,239

Title:	Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor
Abstract:	This application describes a use of an EZH2 inhibitor combined with a BTK inhibitor in preparing a drug for treating a tumor is described.
Inventor(s):	Ma Ke, Cao Guoqing, Yang Changyong, Zhang Lianshan
Assignee:	Jiangsu Hengrui Medicine Co., Ltd.
Application Number:	US16611969
Patent Claims:

Details for Patent 11,065,239

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	November 26, 1997	11,065,239	2038-05-17
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	February 19, 2002	11,065,239	2038-05-17
Btg International Inc.	CROFAB	crotalidae polyvalent immune fab (ovine)	For Injection	103788	October 02, 2000	11,065,239	2038-05-17
Btg International Inc.	VORAXAZE	glucarpidase	For Injection	125327	January 17, 2012	11,065,239	2038-05-17
Amgen Inc.	BLINCYTO	blinatumomab	For Injection	125557	December 03, 2014	11,065,239	2038-05-17
Alexion Pharmaceuticals, Inc.	KANUMA	sebelipase alfa	Injection	125561	December 08, 2015	11,065,239	2038-05-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.